These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23037991)

  • 21. [Capsaicin in treatment of neuropathic pain].
    Kamchatnov PR; Evzelman MA; Abusueva BA; Volkov AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):139-44. PubMed ID: 25629137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
    Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signaling mechanisms of down-regulation of voltage-activated Ca2+ channels by transient receptor potential vanilloid type 1 stimulation with olvanil in primary sensory neurons.
    Wu ZZ; Chen SR; Pan HL
    Neuroscience; 2006 Aug; 141(1):407-19. PubMed ID: 16678970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain.
    Treede RD; Wagner T; Kern KU; Husstedt IW; Arendt G; Birklein F; Cegla T; Freynhagen R; Gockel HH; Heskamp ML; Jager H; Joppich R; Maier C; Leffler A; Nagelein HH; Rolke R; Seddigh S; Sommer C; Stander S; Wasner G; Baron R
    Curr Med Res Opin; 2013 May; 29(5):527-38. PubMed ID: 23444968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
    Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
    J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicity.
    Ursu D; Knopp K; Beattie RE; Liu B; Sher E
    Eur J Pharmacol; 2010 Sep; 641(2-3):114-22. PubMed ID: 20576527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical Capsaicin for the Treatment of Neuropathic Pain.
    Sultana A; Singla RK; He X; Sun Y; Alam MS; Shen B
    Curr Drug Metab; 2021; 22(3):198-207. PubMed ID: 33198614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capsaicin, Nociception and Pain.
    Frias B; Merighi A
    Molecules; 2016 Jun; 21(6):. PubMed ID: 27322240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capsaicin. Neuropathic pain: playing with fire...
    Prescrire Int; 2010 Aug; 19(108):153-5. PubMed ID: 20939441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
    Gavva NR; Bannon AW; Hovland DN; Lehto SG; Klionsky L; Surapaneni S; Immke DC; Henley C; Arik L; Bak A; Davis J; Ernst N; Hever G; Kuang R; Shi L; Tamir R; Wang J; Wang W; Zajic G; Zhu D; Norman MH; Louis JC; Magal E; Treanor JJ
    J Pharmacol Exp Ther; 2007 Oct; 323(1):128-37. PubMed ID: 17652633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
    Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
    Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capsaicin and sensory neurones: a historical perspective.
    Szolcsányi J
    Prog Drug Res; 2014; 68():1-37. PubMed ID: 24941663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel therapeutics in the field of capsaicin and pain.
    Evangelista S
    Expert Rev Clin Pharmacol; 2015; 8(4):373-5. PubMed ID: 25959004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical capsaicin. The fire of a 'hot' medicine is reignited.
    Papoiu AD; Yosipovitch G
    Expert Opin Pharmacother; 2010 Jun; 11(8):1359-71. PubMed ID: 20446852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists.
    Tamayo N; Liao H; Stec MM; Wang X; Chakrabarti P; Retz D; Doherty EM; Surapaneni S; Tamir R; Bannon AW; Gavva NR; Norman MH
    J Med Chem; 2008 May; 51(9):2744-57. PubMed ID: 18386885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the TRPV1 endogenous agonist N-Oleoyldopamine in modulation of nociceptive signaling at the spinal cord level.
    Spicarova D; Palecek J
    J Neurophysiol; 2009 Jul; 102(1):234-43. PubMed ID: 19369364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hot receptors in the brain.
    Steenland HW; Ko SW; Wu LJ; Zhuo M
    Mol Pain; 2006 Nov; 2():34. PubMed ID: 17092351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of capsaicin-sensitive afferents and the Transient Receptor Potential Vanilloid 1 Receptor in xylene-induced nocifensive behaviour and inflammation in the mouse.
    Sándor K; Helyes Z; Elekes K; Szolcsányi J
    Neurosci Lett; 2009 Feb; 451(3):204-7. PubMed ID: 19159661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat.
    Varga A; Németh J; Szabó A; McDougall JJ; Zhang C; Elekes K; Pintér E; Szolcsányi J; Helyes Z
    Neurosci Lett; 2005 Sep; 385(2):137-42. PubMed ID: 15950380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain TRPV1: a depressing TR(i)P down memory lane?
    Di Marzo V; Gobbi G; Szallasi A
    Trends Pharmacol Sci; 2008 Dec; 29(12):594-600. PubMed ID: 18947889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.